Mangoceuticals (MGRX) Total Liabilities (2022 - 2026)

Mangoceuticals' Total Liabilities history runs 5 years deep, the most recent figure standing at $974571.0 for Q1 2026.

• In Q1 2026, Total Liabilities fell 35.17% year-over-year to $974571.0; the TTM figure through Mar 2026 stood at $974571.0 (down 35.17% YoY), while the FY2025 annual figure was $890568.0, down 37.52% from the prior year.
• Total Liabilities came in at $974571.0 for Q1 2026 at Mangoceuticals, up from $890568.0 in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.6 million in Q2 2025 to a low of $240684.0 in Q3 2023.
• A 5-year average of $911916.1 and a median of $932569.5 in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 483.15% in 2024 and sank 42.7% in 2025, its largest moves.
• Mangoceuticals' Total Liabilities stood at $389257.0 in 2022, then fell by 29.09% to $276039.0 in 2023, then surged by 416.4% to $1.4 million in 2024, then slumped by 37.52% to $890568.0 in 2025, then gained by 9.43% to $974571.0 in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $974571.0, $890568.0, and $804275.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison